Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Tim Allen
Piedmont Orthopedics | OrthoAtlanta Welcomes Jeremy Thompson, M.D., Orthopedic Spine Surgeon, to Macon
MACON, Ga., Nov. 10, 2026 /PRNewswire/ — Piedmont Orthopedics | OrthoAtlanta is pleased to welcome Jeremy C. Thompson, M.D., a board-certified orthopedic spine surgeon, to its Macon practice, further expanding access to advanced spine care for patients throughout Middle Georgia. Dr. Thompson specializes in the diagnosis and treatment of cervical, thoracic and lumbar spine conditions, providing a comprehensive range of both nonsurgical and surgical treatment options.
OrthAlign Expands Lantern® ASC Across Hip and Knee Replacement
One platform brings enabling technology across the entire joint replacement program IRVINE, Calif., Nov. 5, 2026 /PRNewswire/ — OrthAlign, Inc., the leader in handheld orthopedic technology, today announced the full commercial launch of Lantern® ASC for total hip and total knee arthroplasty, giving hospitals and ambulatory surgery centers (ASCs) a single platform that brings enabling technology to their entire joint replacement program.
TJO Expands Klassic® Revision Knee to include infection management with the launch of Klassic® Infection Spacer System
Klassic® Knee components replace molded cement in two-stage PJI revision, delivering a stable, functional knee with the single-tray Klassic ONE® instrumentation SALT LAKE CITY, UT, UNITED STATES, November 3, 2026 /EINPresswire.com/ — Total Joint Orthopedics, Inc. (TJO), a developer of hip and knee replacement systems, announces the launch of its Klassic® Infection Spacer System (KISS), expanding the Klassic® Revision Knee System for periprosthetic joint infection (PJI) revision procedures.
Medacta Launches the Mfinity Femoral System at AAHKS 2026, Combining Versatile Implant Design and Efficient Instrumentation
CASTEL SAN PIETRO, Switzerland, November 03, 2026 – Medacta Group SA (“Medacta,” SIX: MOVE) today announces the full commercial release of the Mfinity™ Femoral System in the United States. Designed to accommodate diverse patient anatomies and MIS approaches, Mfinity combines a comprehensive range of stem options with streamlined instrumentation to promote an efficient and reproducible surgical workflow in total hip replacement.
OrthoArizona Surgeon First in the World to Perform Prophecy Incompass Total Ankle Replacement
Dr. Jason Patterson completed three procedures using Stryker’s newest patient-specific ankle technology PHOENIX, Oct. 29, 2026 /PRNewswire/ — Dr. Jason Patterson, an orthopedic surgeon with OrthoArizona, is the first surgeon in the world to perform total ankle replacement surgery using Stryker’s new Prophecy Incompass patient-specific instrumentation. Dr. Patterson completed three procedures in July 2026.
FDA grants 510(k) clearance for BoneEnhance, the first machine learning layer on RIVANNA’s Accuro XV platform
Anatomy segmentation and three-dimensional skeletal visualization arrive with this clearance; an injury detection module for clinical decision support is in development on the platform roadmap CHARLOTTESVILLE, Va., Oct.
Piedmont Orthopedics | OrthoAtlanta Welcomes Zainab Ibrahim, M.D., to Gwinnett
ATLANTA, Oct. 20, 2026 /PRNewswire/ — Piedmont Orthopedics | OrthoAtlanta is pleased to welcome Zainab Ibrahim, M.D., a fellowship-trained orthopaedic surgeon specializing in hip and knee replacement and orthopaedic trauma surgery, to its Gwinnett and Johns Creek locations. Dr. Ibrahim provides comprehensive care for patients with hip and knee arthritis, complex joint replacement needs, and complex fractures and injuries.
Kuros Biosciences increases 2026 annual guidance, The company reports 40% year-over-year increase in sales in the first nine months of 2026
Ad hoc announcement pursuant to Article 53 of the SIX listing rules Kuros Biosciences increases 2026 annual guidance The company reports 40% year-over-year increase in sales in the first nine months of 2026 Schlieren (Zurich), Switzerland, October 15, 2026 – Kuros Biosciences (“Kuros” or the “Company”) a leader in next generation bone healing technologies, today announced its financial performance for the first nine months of 2026.
Centinel Spine® Receives FDA Approval for Two-Level Use of prodisc® C Nova, Further Expanding the Match-The-Disc™ Cervical Portfolio
Centinel Spine® offers an extensive portfolio of cervical total disc replacement (TDR) devices that allows matching the disc to the needs of the patient and surgeon. With this approval, prodisc® C Nova joins prodisc C Vivo and prodisc C SK as three distinct prodisc cervical TDR devices FDA approved for both one- and two-level use, further expanding the Company’s Match-the-Disc™ cervical portfolio.
Globus Medical Schedules Third Quarter Earnings Release and Conference Call
AUDUBON, Pa., Oct. 13, 2026 (GLOBE NEWSWIRE) — Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the third quarter ended September 30, 2026 after the market close on Thursday, November 5, 2026. A copy of the release will be available on the Globus Medical website at www.investors.globusmedical.com.
U.S. Ambulatory Surgery Center Market Reaches $49.19 Billion in 2026 as Outpatient Procedure Migration, Higher-Acuity Cases and ASC Consolidation Reshape U.S. Surgical Care
Ottawa, Oct. 08, 2026 (GLOBE NEWSWIRE) – The U.S. ambulatory surgery center (ASC) market is gaining momentum as healthcare systems, physicians, payers, and investors increasingly shift eligible surgical procedures from hospital settings to cost-efficient outpatient facilities. According to Precedence Research, the U.S. ASC market is valued at USD 49.19 billion in 2026 and is expected to reach USD 84.17 billion by 2035, registering a 6.15% CAGR between 2026 and 2035.
SurGenTec® Enters Exclusive License Agreement with Allevion Medical for Vantage™ Spinal Decompression System
BOCA RATON, Fla., October 8, 2026 /OrthoSpineNews/ – SurGenTec®, a privately held medical device company focused on advancing treatment options for orthopedic and spine surgery, today announced that it has entered into an exclusive license agreement with Allevion Medical for its patented Vantage™ spinal decompression technology.
icotec Receives CMS approval for New Technology Add-On Payment for its CMORE® CT System
NTAP effective October 1, 2026, expanding access to icotec’s radiolucent spinal stabilization technology for eligible Medicare procedures The CMORE® Cervicothoracic (CT) spine implant system is a new key member of icotec’s growing and innovative family of Spine Therapy products ALTSTÄTTEN, Switzerland and BOSTON, Oct.
VB Spine Appoints Thomas E. Oglesby as New Chief Financial Officer
Veteran medtech finance executive brings more than two decades of spine and M&A leadership experience. NEW YORK, October 6, 2026 -(BUSINESS WIRE)- VB Spine LLC (“VB Spineˮ), the largest privately held spine company, today announced the appointment of Thomas E. Oglesby as Chief Financial Officer, effective Sept. 16, 2026. Oglesby joins VB Spine from Zimmer Biomet, where he most recently served as Vice President, Finance for the company’s Sports, Extremities and Trauma global business unit.
Stryker Launches Mako 4 SmartRobotics™ in India, Advancing the Next Generation of Robotic-Assisted Joint Replacement
NEW DELHI, Oct. 5, 2026 /PRNewswire/ — Stryker, a global leader in medical technologies, announced the launch of Mako 4 SmartRobotics™ (Mako 4), the fourth generation of Mako, bringing its latest robotic-arm assisted technology to India.
Xenix Medical Announces FDA Clearance of NanoACTIV™ Surface Technology for Its Riva® Posterior Fixation System
ORLANDO, Fla., October 1, 2026 -(BUSINESS WIRE)- Xenix Medical today announced FDA 510(k) clearance for the addition of NanoACTIV Surface Technology to the screw shanks of its Riva modular pedicle screw system, combining NanoACTIV’s osteogenic properties with the modularity and flexibility of the Riva spinal fixation technology.
SI-BONE Receives FDA 510(k) Clearance for iFuse Granite Onyx™ Extending Its Compromised Bone Franchise Beyond the Pelvis
FDA Breakthrough Device Designated (BDD) platform engineered for durable fixation in low density bone SANTA CLARA, Calif., Sept. 28, 2026 (GLOBE NEWSWIRE) — SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the iFuse Granite Onyx System (Onyx).
Chest Wall Innovations Announces Commercial Launch of the PC Fix Rib Fixation System
Surgeons at hospitals across the United States have completed multiple procedures with PC Fix following FDA 510(k) clearance HERSHEY, Pa., Sept. 28, 2026 /PRNewswire/ — Chest Wall Innovations, Inc., a medical device company dedicated to advancing the surgical treatment of chest wall injuries, today announced the commercial launch of its PC Fix Rib Fixation System. Since receiving FDA 510(k) clearance in April 2026, PC Fix has been used in multiple procedures at hospitals across the United States.
Catalyst OrthoScience Joins Redefine Surgery as Founding Partner in Shoulder
Catalyst and Redefine Surgery announce a partnership that aims to create a surgical intelligence ecosystem that transforms how shoulder replacement is delivered, measured and continuously improved across the full episode of care. NAPLES, Fla., September 24, 2026 -(BUSINESS WIRE)- Catalyst OrthoScience, Inc.
OrthoPediatrics Surpasses 1,000 PNP Tibia Nail Implantations
WARSAW, Ind., Sept. 22, 2026 (GLOBE NEWSWIRE) — OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the recent implantation of the 1,000th Tibia Nail using its latest Pediatric Nailing Platform (PNP). The PNP Tibia System was designed to bring a world-class, pediatric-focused nailing system to surgeons, enabling the use of rigid tibial nails in pediatric patients.
Flixfilm | Nye film og serier på Netflix
Film | 2021 | 156 min | Krimi, Mystik, Thriller Instruktør: Mark Greenstreet Medvirkende: Tim Allen, Susie Amy, John Baldwin Manuskriptforfatter: N/A Land: Storbritannien Sprog: Engelsk IMDB-bedømmelse: 5.2 Den tidligere søofficer og nuværende privatdetektiv John Duval jagter den virkelige forbryder bag flere brutale mord, efter politiet har udråbt ham til hovedmistænkt. Silent Hours havde premiere på Netflix den 21. september 2026. Hvor mange stjerner vil du give Silent Hours?
Synergy Spine Solutions® Highlights Superior Two-Year Clinical Outcomes for FDA-Approved Synergy Disc® at Society for Minimally Invasive Spine Surgery
Two-year primary endpoint data from U.S. IDE clinical trial demonstrates statistical superiority in composite clinical success and improvements in cervical alignment for first-of-its-kind lordotic cervical disc Clinical data presented at the Society for Minimally Invasive Spine Surgery (SMISS) Annual Forum demonstrated that the Synergy Disc achieved an 87.1% composite clinical success (CCS) rate, demonstrating statistical superiority over anterior cervical discectomy and fusion (ACDF) at...
Onkos Surgical® expands access to NanoCept® Antibacterial Technology for patients requiring total femoral replacement
PARSIPPANY-TROY HILLS, N.J., Sept. 17, 2026 /PRNewswire/ — Onkos Surgical today announced the market release of the ELEOSTM Total Femoral Adapter with NanoCept® Antibacterial Technology, expanding the availability of NanoCept for patients undergoing one of the most complex and high-risk orthopaedic reconstruction procedures. Since its introduction in December 2024, NanoCept Antibacterial Technology has been available on ELEOS implant midsections used in complex knee and hip reconstructions.
Shoulder Innovations Announces Exclusive Partnership with ALM Ortho to Introduce Bespoke Solution for Complex Shoulder Reconstruction Procedures
GRAND RAPIDS, Mich., Sept. 9, 2026 /PRNewswire/ — Shoulder Innovations, Inc. (“Shoulder Innovations”, or “the company”) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it has entered into an exclusive collaboration with ALM Ortho, Inc.
Shoulder Innovations Announces Settlement of Patent Litigation with Catalyst OrthoScience
GRAND RAPIDS, Mich., Sept. 8, 2026 /PRNewswire/ — Shoulder Innovations, Inc. (“Shoulder Innovations”) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced that it has entered into a settlement agreement with Catalyst OrthoScience Inc. (“Catalyst”) to resolve all outstanding patent litigation between the two companies. The terms of the settlement agreement are confidential.
Bioretec receives FDA 510(k) clearance for its ActivaScrew™ Cannulated COM bioabsorbable compression screw
September 8, 2026 – Bioretec Ltd (“Bioretec” or the “Company”), a pioneer in bioabsorbable orthopedic implants, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its ActivaScrew™ Cannulated COM bioabsorbable compression screw. The clearance enables the commercialization of the product in the United States in accordance with its cleared indications for use.
Joseph Spine Institute Announces New Regenerative Therapy Center, Offering Advanced Adipose-Derived Cell and PRP Therapies
TAMPA, Fla., Sept. 3, 2026 /PRNewswire/ — Joseph Spine Institute, a nationally recognized leader in advanced spine care and minimally invasive spine surgery, today announced the launch of its Regenerative Therapy Center, expanding the Institute’s comprehensive approach to the treatment of spine and musculoskeletal conditions.
Nanochon Performs First Case in the Chondrograft™ First in Human Clinical Study
BALTIMORE, Sept. 2, 2026 /PRNewswire/ — Nanochon, a medical device company developing Chondrograft™, a novel 3D-printed patented implant for the treatment of articular cartilage defects of the knee, today announced the successful treatment of the first patient in its First-in-Human (FIH) clinical study. The study is designed to evaluate the safety and performance of Chondrograft™ in patients with focal chondral defects of the knee.
Stryker signs definitive agreement to acquire ZuriMED to enhance its shoulder offering
Portage, Mich., USA, Aug. 31, 2026 (GLOBE NEWSWIRE) — Stryker has signed a definitive agreement to acquire ZuriMED, developer of the FiberLocker System, a commercialized technology that provides a novel approach for rotator cuff augmentation designed for increased biomechanical strength. The acquisition strengthens Stryker’s shoulder portfolio, enhancing its ability to support specialists across the continuum of care.
Cornerstone Robotics Announces Strategic Partnership with Medtronic to Expand Global Access to Robotic-assisted Surgery
HONG KONG, Sept. 1, 2026 /PRNewswire/ — Cornerstone Robotics, an innovative surgical robotics company founded and headquartered in Hong Kong, today announced a strategic partnership with Medtronic (NYSE: MDT), a global leader in healthcare technology.
Globus Medical Announces Acquisition of Higgs Boson Health to Transform Healthcare Experience Through AI-Driven Digital Solutions
AUDUBON, Pa., Aug. 26, 2026 (GLOBE NEWSWIRE) — Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced the acquisition of Higgs Boson Health, a digital healthcare experience company based in Durham, NC and incubated out of Duke University. With a mission to transform healthcare experience through digital innovation, Higgs Boson will position Globus Medical to shape patient and provider experience throughout the full episode of care.
OrthoPediatrics Announces Full Commercial Launch of 3P™ Pediatric Plating Platform® Hip System Following More Than 350 Successful Implantations
Successful Limited Launch Demonstrates Demand for Innovative Pediatric-Specific Hip Plating Technology WARSAW, Ind., Aug. 25, 2026 (GLOBE NEWSWIRE) — OrthoPediatrics Corp. (“OrthoPediatrics) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the full commercial launch of its 3P™ Pediatric Plating Platform® Hip System.
FibroBiologics Appoints Leigh Steinberg to Board of Directors
Legendary Sports Agent, Attorney, and Longtime Advocate for Human Longevity and Brain Health Joins Board HOUSTON, Aug. 24, 2026 /PRNewswire/ — FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced the appointment of Leigh Steinberg to its Board of Directors.
Surgical Sutures Market to Grow from USD 4.84 Billion in 2025 to USD 6.65 Billion by 2030, at a CAGR of 6.5% –
Delray Beach, FL, Aug. 20, 2026 (GLOBE NEWSWIRE) — MarketsandMarkets™ projects the global surgical sutures market to grow from USD 4.84 billion in 2025 to USD 6.65 billion by 2030, at a CAGR of 6.5% during the forecast period. The market was valued at USD 4.56 billion in 2024.
Clinical Based Evidence of Eminent Spine’s 3D Printed Titanium Pedicle Screw
Eminent Spine, a leader in advanced 3D implant technology, releases the early clinical and implant results of the world’s first FDA 510(k) approved 3D printed titanium pedicle screw. The proprietary 3D printed pedicle screw, designed and manufactured by Eminent Spine received FDA 510(k) clearance on April 28, 2025. The new novel 3D titanium printing cutting edge technology surpassed the FDA biomechanical testing criteria.
Toy Story 5 Sets Digital, 4K UHD, & Blu-ray Release Dates With Gag Reel & More
and has announced its digital and Blu-ray release date following a successful box-office run. Fans can soon enjoy the beloved movie from the comfort of their homes. Toy Story 5 arrives on digital platforms on August 18, including Amazon Prime Video, Apple TV and Fandango at Home. Meanwhile, the 4K Ultra HD Blu-ray, Blu-ray and DVD will be released on September 22. Additionally, fans can also get their hands on a limited-edition 4K SteelBook® on September 22.
UNFO and OrthoPediatrics Partner to Bring Non-Invasive Foot Brace for Newborns to U.S. Market
Partnership Delivers First Alternative to Painful Casting for Metatarsus Adductus, Affecting Hundreds of Thousands of Newborns Annually TEL AVIV, August 6, 2026 / OrthoSpineNews / – UNFO Med Ltd., manufacturer of the Universal Neonatal Foot Orthotics (UNFO) system, today announced its partnership with OrthoPediatrics to bring its FDA-registered corrective foot brace for Metatarsus Adductus (MTA) to the United States.
Stryker declares an $0.88 per share quarterly dividend
Portage, Michigan, Aug. 05, 2026 (GLOBE NEWSWIRE) — Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.88 per share payable October 30, 2026, to shareholders of record at the close of business on September 30, 2026, representing an increase of 4.8% versus the prior year and unchanged from the previous quarter. About Stryker Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better.
Isto Biologics strengthens its bone graft substitutes platform with the acquisition of NovaBone
HOPKINTON, MA – August 5, 2026 – Isto Biologics (“Isto”), a biologics company dedicated to advancing bone healing, today announced the acquisition of NovaBone Products LLC (“NovaBone”), a developer and manufacturer of synthetic bone graft products, from Halma plc.
Lumbar Disc Herniation Market is Projected to Reach USD 7.2 Billion by 2036 as Novel Therapies and Minimally Invasive Treatments are Gaining Momentum | DelveInsight
The lumbar disc herniation market is anticipated to increase during the forecast period (2026–2036), owing to the launch of emerging therapies and devices, including STA-363 (Stayable Therapeutics), Triojection (SpinaFX Medical), PerQdisc (Spinal Stabilization Technologies), DISC care (NEOS Surgery), and others, and healthcare spending in the 7MM. LAS VEGAS, Aug.
“Hail and Farewell” Celebrates Incoming and Outgoing Fellows at Steadman Philippon Research Institute and The Steadman Clinic
Chairman Marc J. Philippon, MD, CEO Dan Drawbaugh and Co-Director of the Sports Medicine Fellowship Matthew T.
Smith+Nephew’s TESSA™ Spatial Surgery System granted De Novo classification by the FDA sparking a generational leap in Sports Medicine for personalized planning and procedural innovation
Smith+Nephew, July 30, 2026 – (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has been granted De Novo classification by the U.S. Food & Drug Administration (FDA) for its TESSA Spatial Surgery System.
Jonathan Taylor Thomas Reunites with Two ‘Home Improvement’ Co-Stars
Entertainment film classical Sony Love Sony Pictures Classics Acquires Andy Garcia’s ‘Diamond’ Sony Pictures Classics have acquired worldwide rights to award-winning Cuban-American actor and filmmaker Andy Garcia’s crime drama “Diamond,” the company announced Thursday.Premiering at this year’s Cannes Film Festival, the film received a nine-minute standing ovation.Written, directed and produced by Garcia, “Diamond” is a contemporary noir with period sensibilities set in Los Angeles.
VB Spine Receives FDA Clearances of Expanded Indications for Vitoss® Bone Graft Substitute and Interbody Cage Portfolio
NEW YORK, July 29, 2026 -(BUSINESS WIRE)- VB Spine LLC (“VB Spine”) today announced that the U.S. Food and Drug Administration (FDA) granted two 510(k) clearances that expand the indications for its Vitoss® Bone Graft Substitute and interbody cage portfolio.
SpineGuard and Omnia Medical Obtain a New U.S. Patent for Their Innovative Application of DSG Technology to Sacroiliac Joint Fusion
Innovation codeveloped in partnership Acceleration of commercial deployment in the United States PARIS & BOULDER, Colo., July 28, 2026-(BUSINESS WIRE)- Regulatory News: SpineGuard (FR0011464452 – ALSGD), an innovative company specializing in Dynamic Surgical Guidance (DSG®) technology to enhance the safety and efficiency of bone implant placement, and Omnia Medical, an orthopedic implant company focused on innovative spine and sacroiliac solutions, today announced that their U.S. patent...
Leap Distributors Levels Up: Names Dave Ascani CFO
Financial Management Veteran Says He’s Excited to Join ‘Rock Stars of Medical Device Distribution’ DALLAS, TEXAS, July 28, 2026 /OrthoSpineNews/ – Leap Distributors has named Dave Ascani chief financial officer (CFO). As CFO, Ascani will manage the company’s finances and serve as an integral part of the executive management team.
ATEC Announces Participation in Upcoming Investor Conferences
CARLSBAD, Calif., July 27, 2026 -(BUSINESS WIRE)- Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that management will participate in the following investor conference(s): Management will host one-on-one investor meetings at the 11th Annual Needham Virtual MedTech & Diagnostics 1×1 Conference on Monday, August 10, 2026.
Advita Ortho Acquires Bauer Innovations’ Patent Applications for Unique Shoulder Arthroplasty Technologies, Strengthening Advita’s Expanding Shoulder Portfolio
Advita Ortho continues to strengthen its shoulder portfolio through the acquisition of three novel patent applications from Bauer Innovations, supporting future advancements in reverse shoulder arthroplasty.
SurGenTec® Secures FDA Clearance for ION-L™ – Lumbar Navigation Compatible
BOCA RATON, Fla., July 24, 2026 /OrthoSpineNews/ – SurGenTec®, a medical device company focused on advancing treatment options for orthopedic and spine surgery, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its ION-L™ navigation instruments for use with the ION-L™ Lumbar Facet Fixation System.
Bone Biologics Issues Mid-Year Shareholder Update Highlighting Progress Across 2026 Priorities
Strengthened capital position supports continued advancement of NB1 clinical development, manufacturing readiness and intellectual property initiatives through Q2 2027 BURLINGTON, Mass, July 23, 2026 (GLOBE NEWSWIRE) — Bone Biologics Corporation (Nasdaq: BBLG, BBLGW) (“Bone Biologics” or the “Company”), a developer of orthobiologic products for spine fusion markets, today issued a shareholder update summarizing the Company’s progress through the first half of 2026, including its recently...
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Tim
Contact Tim, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack